Cargando…
Hydroxichloroquine for COVID-19 infection: Do we have a final word after one year?
The results presently available from randomised clinical trials and their meta-analysis indicate that Hydroxychloroquine is not associated in COVID-19 patients with either decreased mortality or clinical worsening. Thus, the use of Hydroxychloroquine in COVID-19 patients cannot at present be encoura...
Autores principales: | Di Castelnuovo, Augusto, Costanzo, Simona, Gialluisi, Alessandro, Iacoviello, Licia, de Gaetano, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Federation of Internal Medicine. Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547940/ https://www.ncbi.nlm.nih.gov/pubmed/34750033 http://dx.doi.org/10.1016/j.ejim.2021.10.026 |
Ejemplares similares
-
Machine Learning Approaches for the Estimation of Biological Aging: The Road Ahead for Population Studies
por: Gialluisi, Alessandro, et al.
Publicado: (2019) -
Retrospective Recall of Psychological Distress Experienced During the First COVID-19 Lockdown in Italy: Results From the ALT RISCOVID-19 Survey
por: Bracone, Francesca, et al.
Publicado: (2022) -
Association of Psychological Resilience with All-Cause and Cardiovascular Mortality in a General Population in Italy: Prospective Findings from the Moli-Sani Study
por: Ghulam, Anwal, et al.
Publicado: (2021) -
New challenges from Covid-19 pandemic: an unexpected opportunity to enlighten the link between viral infections and brain disorders?
por: Gialluisi, Alessandro, et al.
Publicado: (2020) -
Dietary Polyphenol Intake Is Associated with Biological Aging, a Novel Predictor of Cardiovascular Disease: Cross-Sectional Findings from the Moli-Sani Study
por: Esposito, Simona, et al.
Publicado: (2021)